HYDRAFIL® is an investigational medical device that is not approved by the United States FDA. For information about clinical studies investigating HYDRAFIL, please go to ClinicalTrials.gov and do a double search – Degenerative Disc Disease and Hydrafil
You should see at least 2 studies:
- NCT04984629 – Calgary, Alberta, Canada
- NCT06011551 – FDA IDE Trial
ClinicalTrials.gov will have up-to-date information about the status of the Company’s clinical investigations of HYDRAFIL and the acceptance requirements. If you see a study that is listed as “Recruiting,” you think that you meet the inclusion and exclusion criteria listed in the description, and you are interested in participating, please contact one of the trial sites listed on clinicaltrials.gov.